How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    Are there any additional equality or health inequalities issues we should consider?

  • Question on Consultation

    Has all of the relevant evidence been taken into account?

  • Question on Document

    Are there any other relevant ongoing studies that address the evidence gaps?

Evidence generation plan for HTE10065 Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres

Open for comments Open until   Request commenting lead permission

We have updated this service so that members of the same organisation can now collaborate on a joint online response.

Read our blog to learn more.

5 Minimum evidence standards

During the evidence generation period, new technologies may become available. This section summarises the minimum evidence requirements that a new technology would need to meet to be considered in the NICE evaluation after the evidence generation period.

The technology that has been recommended for use in the NHS during the evidence generation period has some clinical evidence suggesting that, compared with standard care, it has:

  • comparable diagnostic accuracy results in populations suspected to have either asthma or COPD

  • some evidence on spirometry performance quality assessment and spirometry pattern interpretation

  • some costs and resource-use data showing plausibly cost-effective scenarios for diagnosis of asthma or COPD.

But, more information is still needed to fully understand the benefits it may provide. More evidence is needed on:

  • diagnostic accuracy of the technology, ideally compared with standard care

  • the impact of the technology on the NHS care pathway

  • long-term resource use

  • effectiveness in different subgroups.

This evidence is essential to future NICE decision making. It will also potentially inform the optimum use and implementation of technologies that apply algorithms to spirometry to support asthma and COPD diagnosis in the NHS.